Literature DB >> 8405015

Pharmacokinetic comparison of leucovorin and levoleucovorin.

J Zittoun1, A P Tonelli, J Marquet, E De Gialluly, C Hancock, A Yacobi, J B Johnson.   

Abstract

The pharmacokinetic values of d,l-leucovorin and l-leucovorin were compared in eight healthy volunteers following oral administration of 25 mg d,l-leucovorin and 12.5 mg l-leucovorin. Serum levels of l-5-formyltetrahydrofolate, l-5-methyltetrahydrofolate, and total reduced folates were measured by an established microbiological method. Pharmacokinetic data for both preparations were consistent with those previously reported for d,l-leucovorin, with essentially complete first pass metabolism to l-5-methyltetrahydrofolate, the active metabolite. No differences were found between the two preparations in serum concentrations of active folate fractions, AUC, or Cmax, or in clearance and volume of distribution estimates. These data suggest that after administration of 25 mg of d,l-leucovorin, the d-diastereoisomer has no significant effect on the standard pharmacokinetic measurements of the active l-folates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405015     DOI: 10.1007/bf02440861

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults.

Authors:  B M Mehta; A L Gisolfi; D J Hutchison; A Nirenberg; M G Kellick; G Rosen
Journal:  Cancer Treat Rep       Date:  1978-03

2.  Direct resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate using a bovine serum albumin high-performance liquid chromatographic chiral stationary phase coupled to an achiral phenyl column.

Authors:  I W Wainer; R M Stiffin
Journal:  J Chromatogr       Date:  1988-01-22

Review 3.  Studies with high-dose methotrexate--historical background.

Authors:  A Goldin
Journal:  Cancer Treat Rep       Date:  1978-02

Review 4.  High-dose methotrexate: a critical reappraisal.

Authors:  S P Ackland; R L Schilsky
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

5.  Folinic acid: pharmacokinetics and pharmacodynamics.

Authors:  P F Nixon
Journal:  Clin Exp Pharmacol Physiol Suppl       Date:  1979

6.  Studies on the folic acid activity of human serum.

Authors:  A H WATERS; D L MOLLIN
Journal:  J Clin Pathol       Date:  1961-07       Impact factor: 3.411

7.  Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.

Authors:  L H Matherly; C K Barlowe; I D Goldman
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

8.  Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.

Authors:  J A Straw; E M Newman; J H Doroshow
Journal:  NCI Monogr       Date:  1987

9.  Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration.

Authors:  B W McGuire; L L Sia; P T Leese; M L Gutierrez; E L Stokstad
Journal:  Clin Pharm       Date:  1988-01

Review 10.  New vistas for leucovorin in cancer chemotherapy.

Authors:  W A Bleyer
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

View more
  1 in total

1.  Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags.

Authors:  Seydou Sanogo; Paolo Silimbani; Raffaella Gaggeri; Carla Masini
Journal:  J Oncol Pharm Pract       Date:  2020-04-16       Impact factor: 1.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.